CERC-406

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCERC-406
Drug Alias NameCERC-406
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesES Therapeutics Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A